IVIM Technology (460470) Fundamentals 2026 — Revenue Analysis | SniperIQ
IVIM Technology (460470) is a KR-listed Healthcare company in Medical - Specialties with a market capitalization of ₩43.2B, trading at ₩2860.00 on the KOE. This SniperIQ fundamentals page covers IVIM Technology's valuation, profitability (net margin -87.3%), revenue (₩4.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is IVIM Technology's market cap?
IVIM Technology (460470) has a market capitalization of approximately ₩43.2B, trading at ₩2860.00 on the KOE. Market cap moves with the live share price.
What is IVIM Technology's P/E ratio?
IVIM Technology's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is IVIM Technology?
IVIM Technology runs a net profit margin of -87.3%, a gross margin of 17.6%, and an operating margin of -96.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does IVIM Technology generate?
IVIM Technology reported revenue of ₩4.4B for fiscal year 2025, with net income of -₩3.8B and earnings per share (EPS) of -252. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does IVIM Technology pay a dividend?
IVIM Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is IVIM Technology financially healthy?
IVIM Technology carries a debt-to-equity ratio of 0.06x and a current ratio of 15.74x, with a market beta of 0.47. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is IVIM Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For IVIM Technology (460470) the key facts are: market cap ₩43.2B, revenue ₩4.4B, 52-week range 2680-4945. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track IVIM Technology's full fundamentals live
Get IVIM Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.